According to Zhitong Finance App, Lizhu Pharmaceutical (01513.HK) announced that recently, the company's wholly-owned subsidiary, Zhuhai Lizhu Microsphere Technology Co., Ltd. (hereinafter referred to as “Lizhu Microsphere”), received the “Drug Registration Certificate” (certificate number: 2025S01188) approved and issued by the State Drug Administration, and injectable aripiprazole microspheres were approved for listing.

Zhitongcaijing · 6d ago
According to Zhitong Finance App, Lizhu Pharmaceutical (01513.HK) announced that recently, the company's wholly-owned subsidiary, Zhuhai Lizhu Microsphere Technology Co., Ltd. (hereinafter referred to as “Lizhu Microsphere”), received the “Drug Registration Certificate” (certificate number: 2025S01188) approved and issued by the State Drug Administration, and injectable aripiprazole microspheres were approved for listing.